Haider et al. ACG Case Rep J 2026;13:e01990
Haider et al. ACG Case Rep J 2026;13:e01990
Kannan et al. J Am Coll Surg 2026;242:539–548.
Wang et al. J Am Soc Cytopathol. 2026 Mar 6:S2213-2945(26)00039-6
Kannan et al. JAMA Surg 2026; 1;161(2):171-178
Singhi et al. Annals of Surgical Oncology 2026;242:539–548
Jones et al. Gastrointest Endos. 2025;102(2):223-232.
PITTSBURGH —A molecular test called PancreaSeq accurately classifies pancreatic cysts as potentially cancerous or benign, according to a large, multi-center study led by University of Pittsburgh School of Medicine and UPMC researchers.
Nikiforova MN, Wald AI, Spagnolo DM, Melan MA, Grupillo M, et al. Ann Surg. 2023 May 22.
Paniccia A, Polanco PM, Boone BA, Wald AI, McGrath K, et al. Gastroenterology. 2023 Jan;164(1):117-133.e7.
Pitman MB, Centeno BA, Reid MD, Siddiqui MT, Layfield LJ, et al. Acta Cytol. 2023;67(3):304-320.
PancreaSeq is a product of the Molecular & Genomic Pathology Laboratory at the University of Pittsburgh Medical Center.